参考文章(35)
Kimberly Ku, Jason M. Pogue, Judy Moshos, Suchitha Bheemreddy, Yujing Wang, Ashish Bhargava, Michelle Campbell, Namir Khandker, Paul R. Lephart, Teena Chopra, Kayoko Hayakawa, Emily T. Martin, Odaliz Abreu-Lanfranco, Sorabh Dhar, Keith S. Kaye, Dror Marchaim, Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections. American Journal of Infection Control. ,vol. 40, pp. 983- 987 ,(2012) , 10.1016/J.AJIC.2011.12.014
Wang-Huei Sheng, Jann-Tay Wang, Shu-Ying Li, Yu-Chi Lin, Aristine Cheng, Yee-Chun Chen, Shan-Chwen Chang, Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU. Diagnostic Microbiology and Infectious Disease. ,vol. 70, pp. 380- 386 ,(2011) , 10.1016/J.DIAGMICROBIO.2011.03.003
Antonio T. Freire, Vasyl Melnyk, Min Ja Kim, Oleksiy Datsenko, Oleksandr Dzyublik, Felix Glumcher, Yin-Ching Chuang, Robert T. Maroko, Gary Dukart, C. Angel Cooper, Joan M. Korth-Bradley, Nathalie Dartois, Hassan Gandjini, Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia Diagnostic Microbiology and Infectious Disease. ,vol. 68, pp. 140- 151 ,(2010) , 10.1016/J.DIAGMICROBIO.2010.05.012
Yu-Chung Chuang, Chien-Yu Cheng, Wang-Huei Sheng, Hsin-Yun Sun, Jann-Tay Wang, Yee-Chun Chen, Shan-Chwen Chang, Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis. BMC Infectious Diseases. ,vol. 14, pp. 102- 102 ,(2014) , 10.1186/1471-2334-14-102
G De Pascale, L Montini, T Spanu, V Bernini, A Occhionero, DL Grieco, M Biancone, P De Santis, ES Tanzarella, SL Cutuli, MA Pennisi, MA Antonelli, High-dose tigecycline use in severe infections Critical Care. ,vol. 17, pp. 80- ,(2013) , 10.1186/CC12018
Garyphallia Poulakou, Flora V Kontopidou, Elisabeth Paramythiotou, Maria Kompoti, Maria Katsiari, Efstratios Mainas, Chara Nicolaou, Dimitrios Yphantis, Anastasia Antoniadou, Eleftheria Trikka-Graphakos, Zoi Roussou, Phyllis Clouva, Nina Maguina, Kyriaki Kanellakopoulou, Apostolos Armaganidis, Helen Giamarellou, Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogens. Journal of Infection. ,vol. 58, pp. 273- 284 ,(2009) , 10.1016/J.JINF.2009.02.009
P. Prasad, J. Sun, R. L. Danner, C. Natanson, Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials Clinical Infectious Diseases. ,vol. 54, pp. 1699- 1709 ,(2012) , 10.1093/CID/CIS270
Efthimia Tasina, Anna-Bettina Haidich, Stamatia Kokkali, Malamatenia Arvanitidou, Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis Lancet Infectious Diseases. ,vol. 11, pp. 834- 844 ,(2011) , 10.1016/S1473-3099(11)70177-3
S. Swoboda, M. Ober, C. Hainer, C. Lichtenstern, C. Seiler, C. Wendt, T. Hoppe-Tichy, M. Buchler, M. A. Weigand, Tigecycline for the treatment of patients with severe sepsis or septic shock: a drug use evaluation in a surgical intensive care unit Journal of Antimicrobial Chemotherapy. ,vol. 61, pp. 729- 733 ,(2008) , 10.1093/JAC/DKM541
Jason C Gallagher, Heather M Rouse, Tigecycline for the Treatment of Acinetobacter Infections: A Case Series Annals of Pharmacotherapy. ,vol. 42, pp. 1188- 1194 ,(2008) , 10.1345/APH.1L171